CD73 expression in normal and pathological human hepatobiliopancreatic tissues.

Amedeo SciarraInês MonteiroChristine Ménétrier-CauxChristophe CauxBenoit GilbertNermin HalkicStefano La RosaPedro RomeroChristine SempouxLaurence de Leval

Published in: Cancer immunology, immunotherapy : CII (2019)

Consistent CD73 expression supports the rationale for testing anti-CD73 therapies in patients with hepatobiliopancreatic malignancies. Specific patterns of expression could also be of help in the routine diagnostic workup.

Keyphrases

poor prognosis
binding protein
endothelial cells
gene expression
clinical trial
long non coding rna
clinical practice